DGX — QUEST DIAGNOSTICS INC
Public company
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
Why are billionaires buying DGX?
Built from public SEC filings and public economic data. Not a recommendation.
Why? — Evidence & Confidence ▾
Of 1 tracked investors who changed their DGX position last quarter, 1 bought and 0 sold (100% buy-side). Macro conditions are mixed for this sector (Macro Tailwind 56/100 in a Overheat regime). 2 congressional purchases, 0 sales disclosed in the last 6 months.
- +1 tracked investor added or increased positions last quarter (Ray Dalio)
- +5 tracked investors reported holding DGX at their latest filing
- +Macro Health is 56/100 in a Overheat regime — historically acceptable for this sectorsource
- +2 congressional purchases disclosed in the last 6 months
- −13F data is disclosed up to 45 days after quarter end — positions may have changed since
- · 13F disclosure lag (up to 45 days)
- · Tracked investors are a sample, not the whole market
- · Sector regime fit is a historical average, not a guarantee
Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 9/18/2026.
About QUEST DIAGNOSTICS INC (DGX)
QUEST DIAGNOSTICS INC (DGX) appears in the most recent 13F filings of 5 tracked institutional investors. The largest disclosed position is held by Ken Griffin (Citadel Advisors), valued at $180M. Across recent filings, tracked investors recorded 2 new positions, 4 increased, 8 reduced, and 0 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in DGX
How many top investors track DGX
A small number of top investors own this.
DGX Ownership Composition
How QUEST DIAGNOSTICS INC is held across tracked investor types, based on reported 13F positions.
- Multi-Strategy / Quant87.9%
- Macro12.1%
Tracked investors currently reporting DGX
- Ken GriffinJun 30, 2026Citadel AdvisorsShares277.2KValue$58.8M% Portfolio0.01%
- Izzy EnglanderJun 30, 2026Millennium ManagementShares24.4KValue$5.2M% Portfolio0.00%
- Steve CohenJun 30, 2026Point72 Asset ManagementShares23.4KValue$5M% Portfolio0.01%
- Ray DalioJun 30, 2026Bridgewater AssociatesShares3.8KValue$796.1K% Portfolio0.00%
- Paul Tudor JonesJun 30, 2026Tudor Investment CorpShares41KValue$8.7M% Portfolio0.01%
Recent activity
- New$43.4KNov 14, 2025
- Increased$87.6K(121.64%)Feb 17, 2026
- Reduced$27.8M(-18.07%)Feb 14, 2024
- Reduced$26.3M(-1.88%)May 14, 2024
- Reduced$19.7M(-27.34%)Aug 14, 2024
- Reduced$13.8M(-38.25%)Nov 13, 2024
- Reduced$3.3M(-75.33%)Feb 13, 2025
- Increased$5M(33.70%)May 14, 2025
- Reduced$677.4K(-87.12%)Aug 13, 2025
- Increased$1.1K(49.72%)Nov 13, 2025
- Reduced$610(-37.69%)Feb 13, 2026
- Reduced$680.2K(-1.34%)May 15, 2026
- Increased$796.1K(8.21%)Aug 14, 2026
- New$30MNov 13, 2023
Frequently asked questions
- How many institutional investors hold DGX?
- 5 tracked institutional investors disclosed a position in DGX (QUEST DIAGNOSTICS INC) in their most recent 13F filing.
- Who is the largest institutional holder of DGX?
- Ken Griffin, Citadel Advisors, holds the largest disclosed position in DGX, valued at $180M.
- Did institutional ownership of DGX increase or decrease?
- Across recent 13F filings, tracked investors recorded 2 new positions, 4 increased, 8 reduced, and 0 fully exited DGX.
- Where does this DGX ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.